The below Parliamentary question was asked by Greg Mulholland on 2015-10-12.
To ask the Secretary of State for Health, if he will place in the Library a copy of all previous and current materials used for the healthWRAP training course.
Jane Ellison
Copies of healthWRAP training materials have been placed in the Library.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Work and Pensions, what assessment he has made of the effectiveness of anonymising job applications in tackling discrimination in the jobs market.
Priti Patel
The department has made no specific assessment of the effectiveness of anonymising job applications in tackling discrimination in the jobs market.
Early discussions are currently taking place between DWP and large employers through employer roundtables about the scope for reforming recruitment policy through anonymised applications.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-12.
To ask the Secretary of State for the Home Department, what progress has been made on ensuring police record instances of Islamophobic hate crime.
Karen Bradley
Hate crime has no place in Britain and this government is determined to make further progress to tackle this crime. We have asked police forces in England and Wales to record anti-Muslim hate crime as a specific category in the recorded crime statistics from April 2016. This will help forces to build community trust, target their resources and enable the public to hold them to account. Addressing the harm that Islamophobia causes is a key part of our new Counter-Extremism Strategy which will be published later this month.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-14.
To ask the Secretary of State for the Home Department, for what length of time her Department retains information about a person after they have been referred to the Channel programme.
Mr John Hayes
Information relating to an individual referred to Channel is recorded by the police on the Channel Case Management and Information System (CMIS). The data is subject to the Code of Practice on the Management of Police Information (MOPI).
The below Parliamentary question was asked by Greg Mulholland on 2015-10-14.
To ask the Secretary of State for the Home Department, what proportion of Prevent strategy funding for each of the last five years has been allocated to tackling far right extremism.
Mr John Hayes
The Prevent Strategy addresses all forms of terrorism including extreme right wing terrorism. We do not provide a breakdown of Prevent project spending for reasons of national security.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-14.
To ask the Secretary of State for the Home Department, what indicators are used by the Government and local authorities to assess the effectiveness of initiatives funded by the Prevent strategy.
Mr John Hayes
The Government has developed a comprehensive approach to assessing the effectiveness of the initiatives funded by the Prevent strategy, including output measures as well as an increased focus on impact and outcomes.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-14.
To ask the Secretary of State for the Home Department, what the membership of the Community Engagement Forum is.
Mr John Hayes
The Community Engagement Forum met for the first time on 13 October. Attendance at forum meetings will rotate to allow ministers to hear directly from a wide range of individuals and groups taking a leading role in challenging extremism in our communities.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, what timetable NHS England has set for developing a commissioning policy for the Everolimus drug.
George Freeman
NHS England is currently developingtwo policies for the provision of Everolimus – one for the Tuberous Sclerosis forComplex Related Renal Angiomyolipoma andone for SubependymalGiant Cell Astrocytoma (SEGA). This was communicated to the National Health Service in a Specialised Services Circular on 2 July 2015.
These two policies will both be considered as in-year items for the specialised services work programme for 2015/16- however, a timetable for publication has not yet been agreed.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, when he expects NICE to publish its final guidance on the Vimizim treatment.
George Freeman
The National Institute for Health and Care Excellence currently expects to publish its final guidance on elosulfase alfa (Vimizim) for mucopolysaccharidosis (type IVA) or Morquio Syndrome in December 2015.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, what recent representations (a) NHS England and (b) NICE have received from (i) drug companies and (ii) patient groups on the treatment of uveitis.
Alistair Burt
NHS England has received 12 letters from hon. Members and has met with key stakeholders, including patient organisations and charities such as the Royal National Institute of Blind People and Olivia’s Vision. This followed their decision in July not to fund Infliximab (Remicade) and Adalimumab (Humira), Anti-TNF drugs, as a treatment for adults and children with severe refractory uveitis.
NHS England has also been in discussion with Abbvie, a Pharmaceutical Research and Development Company which is due to report on their trial of Adalimumab in adults in early 2016.
The National Institute for Health and Care Excellence (NICE) is developing technology appraisal guidance on the use of the drugs dexamethasone and sorolimus for the treatment of uveitis. NICE develops its technology appraisal guidance in consultation with a broad range of stakeholders and the representations it receives in the development of its guidance will be available on the NICE website at:
http://www.nice.org.uk/guidance/indevelopment/gid-ta10007
NICE has not received any representations about uveitis not related to this ongoing technology appraisal.
“